
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE
@bettykimlab
Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own
ID: 701854419277643776
22-02-2016 19:41:48
1,1K Tweet
1,1K Followers
779 Following


π’ Read the full paper in Nature Cancer here: rdcu.be/ebeVG Deeply thankful to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and @wenjiang_nano for their mentorship and support and all lab members Yifan Wang, PhD , Annette Wu, Kristin Huntoon, @DYLee_BME , Shiyan Dong , Mengyu Chang, Adam Grippin , Yifan


Congrats Benjamin Schrank, MD, PhD on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer MD Anderson Cancer Center nature.com/articles/s4301β¦

Thanks Albert Koong, MD PhD for your encouragement along the way. Your mentorship shapes the growth of trainees like myself MD Anderson Cancer Center and beyond


Thank you β¦ASCO for featuring our study:β© Novel Antibody-Toxin Conjugate Evaluated in Early Study Stay tuned as we work towards bringing this to our patients β¦MD Anderson Cancer Centerβ© β¦Benjamin Schrank, MD, PhDβ© β¦Yifan Wang, PhDβ© ascopost.com/news/february-β¦


Benjamin Schrank, MD, PhD Nature Cancer Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @wenjiang_nano We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/blog/benjamin-β¦

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate MD Anderson Cancer Center Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to


Why do tumors evade immune detection, even when phagocytosed? - Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE MD Anderson Cancer Center Yifan Wang, PhD @DYLee_BME Annette Wu oncodaily.com/blog/benjamin-β¦ #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound Jacques Lux Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Yifan Wang, PhD U of A College of Medicine Neurosurgery advanced.onlinelibrary.wiley.com/doi/10.1002/adβ¦

Partners today for #ACLS Saving lives with β¦Benjamin Schrank, MD, PhDβ© β¦MD Anderson Cancer Centerβ©




π Excited to share in Nature Rev Immunol a Mark Yarmarkovich NYU Langone Health study that dramatically expands the known repertoire of tumour-specific peptides for #tcelltherapies. Huge thanks to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and the Preprint Club - Immunology for the cross-instituional collaboration nature.com/articles/s4157β¦



Thrilled to share that Iβve joined MD Anderson Cancer Center as an Assistant Professor & Physician-Scientist in Radiation Oncology--and Iβm launching my lab! Weβre building a research program at the intersection of genome instability, tumor immunology, and therapeutic development -- and

Iβve Joined MD Anderson Cancer Center as an Assistant Professor and Physician-Scientist in Radiation Oncology - Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Albert Koong, MD PhD oncodaily.com/blog/benjamin-β¦ #RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc

